Development of quality of care indicators for Parkinson's disease

Parkinson's disease (PD) is a major cause of disability. To date, there have been no large‐scale efforts to measure the quality of PD care because of a lack of quality indicators for conducting an explicit review of PD care processes. We present a set of quality indicators for PD care. Based on a structured review of the medical literature, 79 potential indicators were drafted. Through a two‐round modified Delphi process, an expert panel of seven movement disorders specialists rated each indicator on criteria of validity, feasibility, impact on outcomes, room for improvement, and overall utility. Seventy‐one quality indicators met validity and feasibility thresholds. Applying thresholds for impact on outcomes, room for improvement, and overall utility, a subset of 29 indicators was identified, spanning dopaminergic therapy, assessment of functional status, assessment and treatment of depression, coordination of care, and medication use. Multivariable analysis showed that overall utility ratings were driven by validity and impact on outcomes (P < 0.01). An expert panel can reach consensus on a set of highly rated quality indicators for PD care, which can be used to assess quality of PD care and guide the design of quality improvement projects. © 2003 Movement Disorder Society

[1]  C. Benesch,et al.  Development of Performance Measures for Acute Ischemic Stroke , 2001, Stroke.

[2]  A. Nezu,et al.  American College of Physicians. , 1932, California and western medicine.

[3]  S Kamen,et al.  The task force. , 1976, Journal of hospital dental practice.

[4]  E. McGlynn,et al.  How good is the quality of health care in the United States? , 1998, The Milbank quarterly.

[5]  A. Siderowf,et al.  Diagnosis and treatment of Parkinson's disease: a systematic review of the literature. , 2003, Evidence report/technology assessment.

[6]  P. Shekelle,et al.  Assessing Care of Vulnerable Elders: ACOVE Project Overview , 2001, Annals of Internal Medicine.

[7]  T. Chow,et al.  Quality Indicators for Dementia in Vulnerable Community-Dwelling and Hospitalized Elders , 2001, Annals of Internal Medicine.

[8]  K. Marder,et al.  An estimate of the incidence of depression in idiopathic Parkinson's disease. , 1992, Archives of neurology.

[9]  Alastair Baker,et al.  Crossing the Quality Chasm: A New Health System for the 21st Century , 2001, BMJ : British Medical Journal.

[10]  C M Ashton,et al.  An empirical assessment of the validity of explicit and implicit process-of-care criteria for quality assessment. , 1999, Medical care.

[11]  R. Baker,et al.  Fortnightly Review: Development of review criteria: linking guidelines and assessment of quality , 1995, BMJ.

[12]  J. Feussner,et al.  The Quality Enhancement Research Initiative (QUERI): from evidence to action. , 2000, Medical care.

[13]  A. Hutchinson,et al.  Research methods used in developing and applying quality indicators in primary care , 2002, BMJ : British Medical Journal.

[14]  Kathleen N Lohr,et al.  Screening for Depression in Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[15]  D. Zucker.  Design and Analysis of Cluster Randomization Trials , 2003 .

[16]  Tx Station.  Stata Statistical Software: Release 7. , 2001 .

[17]  Cindy Farquhar,et al.  3 The Cochrane Library , 1996 .

[18]  Paul Shekelle,et al.  Assessing Care of Vulnerable Elders: Methods for Developing Quality Indicators , 2001, Annals of Internal Medicine.

[19]  P. Shekelle,et al.  Impact of varying panel membership on ratings of appropriateness in consensus panels: a comparison of a multi- and single disciplinary panel. , 1995, Health services research.

[20]  R H Brook,et al.  Quality-of-care assessment: choosing a method for peer review. , 1973, The New England journal of medicine.

[21]  B. Mittman,et al.  Physicians’ Preferences for Specialty Involvement in the Care of Patients With Neurological Conditions , 2002, Medical care.

[22]  L. Leape,et al.  Variations by specialty in physician ratings of the appropriateness and necessity of indications for procedures. , 1996, Medical care.

[23]  José Maria Paganni,et al.  Evaluating the quality of medical care. , 1966, The Milbank Memorial Fund quarterly.

[24]  C. C. Johnson,et al.  Demographic differences in referral rates to neurologists of patients with suspected Parkinson's disease: implications for case-control study design. , 1995, Neuroepidemiology.

[25]  P. Czernichow,et al.  Growth in Paediatric Crohn’s Disease , 2002, Hormone Research in Paediatrics.

[26]  P. Shekelle,et al.  ACOVE Quality Indicators , 2001, Annals of Internal Medicine.

[27]  K. Marder,et al.  The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. , 1995, American journal of epidemiology.

[28]  G. Guyatt,et al.  Grades of recommendation for antithrombotic agents. , 1998, Chest.

[29]  C M Ashton,et al.  A Method of Developing and Weighting Explicit Process of Care Criteria for Quality Assessment , 1994, Medical care.

[30]  C. Naylor.  What is appropriate care? , 1998, The New England journal of medicine.

[31]  Fabrizio Stocchi,et al.  Factors impacting on quality of life in Parkinson's disease: Results from an international survey , 2002, Movement disorders : official journal of the Movement Disorder Society.

[32]  J. Cummings,et al.  The occurrence of depression in Parkinson's disease. A community-based study. , 1996, Archives of neurology.

[33]  L. E. Peterson,et al.  Eliciting expert opinion using the Delphi technique: identifying performance indicators for cardiovascular disease. , 1998, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[34]  Andrew J. Lees,et al.  Management of Parkinson's disease: An evidence‐based review , 2002, Movement disorders : official journal of the Movement Disorder Society.